Abnormal GPL metabolism, represented by phosphatidylcholine (PC), has been confirmed to play a considerable role in inflammation, hypertension, and tumors (Sonkar et al., 2019; Sun et al., 2021; Chen Q. et al., 2022). This evidence concerns the gene IL31RA and hypertensive disorder.